Korlym and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Korlym (mifepristone) and Profen (ibuprofen). Common drug interactions include joint swelling among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Korlym and Profen. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,312 Profen users. Check the latest studies of Profen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

70 people who take Korlym and Profen together, and have interactions are studied.

Korlym and Profen drug interactions.

What are the common drug interactions of Korlym and Profen, by gender? *:

female:

  1. Joint swelling
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Nasal polyps (masses that develop in the lining of the nose)
  4. Piloerection (goose bumps)
  5. Procedural pain
  6. Protein total decreased
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Swelling
  10. Uterine polyp (a mass in the inner lining of the uterus)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Aggression
  4. Asthenia (weakness)
  5. Aura
  6. Blood calcium increased
  7. Blood glucose decreased
  8. Blood glucose fluctuation
  9. Blood glucose increased
  10. Blood thyroid stimulating hormone decreased

What are the common drug interactions of Korlym and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Agitation (state of anxiety or nervous excitement)
  2. Abdominal pain lower
  3. Acne (skin problems that cause pimples)
  4. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  5. Arthralgia (joint pain)
  6. Blood glucose fluctuation
  7. Blood pressure fluctuation
  8. Blood pressure increased
  9. Blood urine present
  10. Constipation

40-49:

  1. Vaginal haemorrhage (vaginal bleeding)
  2. Nausea (feeling of having an urge to vomit)
  3. Abdominal discomfort
  4. Blood glucose decreased
  5. Blood potassium decreased
  6. Headache (pain in head)
  7. Hyperthyroidism (over activity of the thyroid gland)
  8. Vomiting
  9. Fatigue (feeling of tiredness)
  10. Alopecia (absence of hair from areas of the body)

50-59:

  1. Blood pressure decreased
  2. Blood pressure increased
  3. Breast tenderness
  4. Glycosylated haemoglobin increased
  5. Heart rate increased
  6. Hyperhidrosis (abnormally increased sweating)
  7. Influenza
  8. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Streptococcal urinary tract infection (a bacterial infection of urinary tract)

60+:

  1. Blood pressure increased
  2. Fatigue (feeling of tiredness)
  3. Constipation
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Renal impairment (severely reduced kidney function)
  6. Vascular occlusion (sudden blockage of a blood vessel, usually with a clot)
  7. Diarrhoea
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Vomiting
  10. Blood potassium decreased

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 61 people, 87.14%
  2. Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 5 people, 7.14%
  3. Type 2 Diabetes: 4 people, 5.71%
  4. High Blood Pressure: 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Korlym and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Korlym and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mifepristone and ibuprofen (the active ingredients of Korlym and Profen, respectively), and Korlym and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: